ApprovalTrail

Approval · Notice of Compliance 2871 · 1998

ENFLURANE USP: Notice of Compliance 2871

Issued April 15, 1998

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
2871
Date
April 15, 1998
Company
Technilab Pharma Inc.Mirabel, Quebec, Canada
Product type
Prescription Pharmaceutical
Submission
Abbreviated New Drug Submission (ANDS)
Submission class
Other
Therapeutic class
Inhalation anesthetic
Canadian reference product
ETHRANE

Products in this notice

BrandDINStatus today
ENFLURANE USP02237683—

Medicinal ingredients